Literature DB >> 19697592

Coagulation and anticoagulation in pulmonary arterial hypertension.

Gidon Berger1, Zaher S Azzam, Ron Hoffman, Mordechai Yigla.   

Abstract

Pulmonary arterial hypertension is a complex pulmonary vascular disease with a broad range of abnormal vascular abnormalities. Vasoconstriction, remodeling and thrombosis contribute to some extent to increased pulmonary vascular resistance and pressure. This review presents current knowledge on the role of the thrombotic process in the pathogenesis of PAH and evaluates the rationale for anticoagulation therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697592

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  15 in total

1.  Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling.

Authors:  Vadim Shlyonsky; Robert Naeije; Frédérique Mies
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

2.  Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.

Authors:  Shu-Zhen Xu; Xiang-Pei Li; Xiao-Mei Li; Zong-Wen Shuai; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2018-03-08       Impact factor: 2.980

3.  Platelet TLR4: a critical link in pulmonary arterial hypertension.

Authors:  Zhongjie Sun
Journal:  Circ Res       Date:  2014-05-09       Impact factor: 17.367

4.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

Review 5.  Tissue factor, protease activated receptors and pathologic heart remodelling.

Authors:  Silvio Antoniak; Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

6.  Platelet activation contributes to hypoxia-induced inflammation.

Authors:  Cassidy Delaney; Pavel Davizon-Castillo; Ayed Allawzi; Janelle Posey; Aneta Gandjeva; Keith Neeves; Rubin M Tuder; Jorge Di Paola; Kurt R Stenmark; Eva S Nozik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-02       Impact factor: 5.464

7.  Platelets in pulmonary hypertension: a causative role or a simple association?

Authors:  Keyhan Sayadpour Zanjani
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

8.  Control strategy on hypertension in chinese medicine.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-12       Impact factor: 2.629

9.  Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.

Authors:  Abdulhalim Awad; Shimaa Elnemr; Hossam Hodeib; Doaa El Amrousy
Journal:  Pediatr Cardiol       Date:  2022-03-02       Impact factor: 1.838

10.  Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.

Authors:  Katrin F Nickel; Volker Laux; Rolf Heumann; Georges von Degenfeld
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.